Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 19 February 1999:
Vol. 283. no. 5405, pp. 1100 - 1103
DOI: 10.1126/science.283.5405.1100

News Focus

From Junk Bond King to Cancer Crusader

Erik Stokstad

Once called the most powerful man in American finance, Michael Milken is now putting the energy, contacts, and ambition that once earned him billions on Wall Street into finding a cure for prostate cancer. Within a month of being diagnosed with an advanced case of the disease at the age of 46, he set up a foundation that has raised both the public and scientific profile of prostate cancer research. He has brought to the field a survivor's sense of urgency, vast amounts of cash, and a knack for remaking organizations. And in the process, he is shaking up the culture of the prostate cancer research community.

Read the Full Text





To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)